The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers.
作者信息
Geck P, Sonnenschein C, Soto A M
出版信息
Am J Hum Genet. 2001 Aug;69(2):461-3. doi: 10.1086/321968.
Abstract
摘要
相似文献
1
The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers.
Am J Hum Genet. 2001 Aug;69(2):461-3. doi: 10.1086/321968.
2
Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
Hum Genet. 1996 Jul;98(1):80-5. doi: 10.1007/s004390050164.
3
Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.
Genes Chromosomes Cancer. 1995 Aug;13(4):291-4. doi: 10.1002/gcc.2870130410.
4
Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
Am J Hum Genet. 1996 Sep;59(3):547-53.
5
Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Cancer. 2000 Nov 1;89(9):1933-45. doi: 10.1002/1097-0142(20001101)89:9<1933::aid-cncr9>3.3.co;2-4.
6
Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype.
Am J Hum Genet. 1996 Apr;58(4):749-56.
7
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
Br J Cancer. 1995 Nov;72(5):1241-4. doi: 10.1038/bjc.1995.493.
8
A large multisite cancer family is linked to BRCA2.
J Med Genet. 1995 Dec;32(12):982-4. doi: 10.1136/jmg.32.12.982.
9
[A genetic test for breast cancer: curse or blessing?].
Fortschr Med. 1995 Feb 10;113(4):9-10.
10
Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Eur J Cancer. 1999 Nov;35(12):1730-4. doi: 10.1016/s0959-8049(99)00205-1.
引用本文的文献
1
PDS5A and PDS5B in Cohesin Function and Human Disease.
Int J Mol Sci. 2021 May 30;22(11):5868. doi: 10.3390/ijms22115868.
2
Downregulation of APRIN expression increases cancer cell proliferation via an interleukin-6/STAT3/cyclin D axis.
Oncol Lett. 2021 Jan;21(1):55. doi: 10.3892/ol.2020.12317. Epub 2020 Nov 18.
3
Brca2, Pds5 and Wapl differentially control cohesin chromosome association and function.
PLoS Genet. 2018 Feb 15;14(2):e1007225. doi: 10.1371/journal.pgen.1007225. eCollection 2018 Feb.
4
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.
EMBO J. 2012 Mar 7;31(5):1160-76. doi: 10.1038/emboj.2011.490. Epub 2012 Jan 31.
5
APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.
J Steroid Biochem Mol Biol. 2008 Jan;108(1-2):32-43. doi: 10.1016/j.jsbmb.2007.05.034. Epub 2007 Sep 12.
6
Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.
Am J Hum Genet. 2003 Oct;73(4):748-67. doi: 10.1086/378522. Epub 2003 Sep 16.
本文引用的文献
1
Polymorphism and allelic loss at the AS3 locus on 13q12-13 in esophageal squamous cell carcinoma.
Int J Oncol. 2001 May;18(5):1003-7. doi: 10.3892/ijo.18.5.1003.
2
Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.
Am J Hum Genet. 2001 Feb;68(2):546. doi: 10.1086/318211.
3
Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Cancer. 2000 Nov 1;89(9):1933-45. doi: 10.1002/1097-0142(20001101)89:9<1933::aid-cncr9>3.3.co;2-4.
4
Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator.
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10185-90. doi: 10.1073/pnas.97.18.10185.
5
Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
Am J Hum Genet. 2000 Jun;66(6):1963-8. doi: 10.1086/302922. Epub 2000 Apr 28.
6
Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Eur J Cancer. 1999 Nov;35(12):1730-4. doi: 10.1016/s0959-8049(99)00205-1.
7
Overexpression of BRCA2 gene in sporadic breast tumours.
Oncogene. 1999 Sep 16;18(37):5232-8. doi: 10.1038/sj.onc.1202903.
8
Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Cancer Res. 1999 Aug 1;59(15):3724-9.
9
Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus.
J Steroid Biochem Mol Biol. 1999 Jan;68(1-2):41-50. doi: 10.1016/s0960-0760(98)00165-4.
10
Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.
Int J Cancer. 1998 Sep 25;78(1):1-7. doi: 10.1002/(sici)1097-0215(19980925)78:1<1::aid-ijc1>3.0.co;2-u.
Zotero 插件